VIVO - Meridian Bioscience, Inc

Healthcare - Sector

VIVO is currently covered by 2 analysts with average potential upside of $4.89 (23.24%) backed by 18 price targets and 24 ratings. Analyst's average stock valuation to be materialised ratio is 75.56% with an average time for price targets to be met of 227.67 days.

Most recent stock forecast was given by YI CHEN from HCWAINWRIGHT on 08-Jul-2022.

Highest price target for VIVO is 33, Lowest price target is 19, average price target is 26.

Best performing analysts who are covering VIVO - Meridian Bioscience, Inc:

Yi Chen Steven Mah Mark Massaro

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

34

$2.42 (7.66%)

30

4 months 21 days ago

6/9 (66.67%)

$7.46 (35.31%)

337

Buy

34

$2.42 (7.66%)

34

1 years 9 months 6 days ago

3/5 (60%)

$6.01 (27.76%)

42

Sell

9

$-22.58 (-71.50%)

11

3 years 6 months 28 days ago

9/9 (100%)

$1.19 (6.64%)

304

Show more analysts

This chart will make you best informed on how analysts see your stock and which of them does well in less than two minutes.

28 days free trial

We do our best to collect, sort, and check every available news item on your stocks so that you can focus on what is important

For each analyst know for every call if it has been before or after the stock price moved

Understand how each analyst reacts to stock price movement

Get Started or Login